Drugs
AMA Urges HHS to Withdraw Policy Allowing Unapproved Peptides
The American Medical Association is urging HHS to rescind a proposed enforcement discretion policy that would permit pharmacies and physicians to compound six unapproved peptides, warning that the policy could expose patients to substances that have not undergone FDA reviews for safety, effectiveness or quality. In a recent letter to